ArticleMolecular neurodegeneration2017

Pathogenic LRRK2 variants are gain-of-function mutations that enhance LRRK2-mediated repression of β-catenin signaling.

Daniel C Berwick et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.